Meeting Agenda
Agenda
8:00 - 8:10 a.m. Welcome and Introductions
Marie McCormick, MD, ScD
Chair, Immunization Safety Review Committee
8:10 - 8:30 a.m. Risk Assessment of Thimerosal in Childhood Vaccines
Leslie K. Ball, MD
Division of Vaccines and Related Product Applications
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Food and Drug Administration
8:30 - 9:00 a.m. History of Thimerosal Concern and Comparative Policy
Actions
Gary L. Freed, MD
The Percy and Mary Murphy Professor of Pediatrics and Child Health Delivery
Director, Division of General Pediatrics
Professor of Health Management and Policy
University of Michigan
Margie Andreae, MD
Associate Director for Clinical Services
Division of General Pediatrics
University of Michigan
9:00 - 9:35 a.m. Biologic Plausibility and Planned Research
Jane M. El-Dahr, MD
Head, Section of Pediatric Allergy, Immunology, Rheumatology
Tulane University Health Sciences Center
David S. Baskin, MD
Professor of Neurosurgery
Baylor College of Medicine
9:35 - 10:00 a.m. The Role of Heavy Metals in Autism
Jeffrey Bradstreet, MD
Director of Research
The International Autism Research Center
10:00 - 10:15 a.m. Break
10:15 - 10:45 a.m. Pharmacokinetic Modeling of Hair Mercury Levels from
Thimerosal
David Brown, ScD
Toxicologist and Independent Consultant
Connecticut
10:45 - 11:30 a.m. Vaccine Safety Datalink (VSD) Screening Study and
Follow-up Analysis with Harvard Pilgrim Data
Thomas Verstraeten, MD, MSc
EIS Officer, National Immunization Program
Centers for Disease Control and Prevention
11:30 - 12:00 p.m. Protocol for National Immunization Program Study on
Thimerosal
Paul Stehr-Green, DrPH, MPH
Associate Professor of Epidemiology
University of Washington School of Community Medicine and Public Health
William Thompson, PhD (for Q&A period only)
Epidemiologist, National Immunization Program
Centers for Disease Control and Prevention
12:00 - 1:00 p.m. Lunch (on your own)
1:00 - 1:30 p.m. Seychelles Islands Study
Gary Myers, MD
Professor of Neurology and Pediatrics
University of Rochester School of Medicine and Dentistry
1:30 - 2:00 p.m. Faroe Islands Study
Philippe Grandjean, MD, DMSc
Institute of Community Health
Odense University, Denmark
OR (TBD)
Roberta White, PhD
Professor, Environmental Health and Neurology
Boston University Schools of Medicine and Public Health
2:00 - 2:30 p.m. In Vitro Studies of Thimerosal Toxicity
Boyd E. Haley, PhD
Chairman and Professor, Department of Chemistry
University of Kentucky
2:30 - 3:00 p.m. Comparative Toxicology of Ethyl and Methyl Mercury
George Lucier, PhD
Former Director, Environmental Toxicology Program
National Institute for Environmental Health Sciences
3:00 - 3:15 Break
3:15 - 3:30 Rising Incidence of Autism: Association with Thimerosal
Mark F. Blaxill, MBA
Autism Society of America, Massachusetts Chapter
3:30 - 3:45 p.m. NIH Studies on Thimerosal
Polly Sager, PhD
National Institute of Allergies and Infectious Diseases
National Institutes of Health
3:45 - 4:10 p.m. Wrap-up Commentary on Thimerosal Risk
From the Perspective of a Developmental Toxicologist
George Lambert, MD
Environmental and Occupational Health Sciences Institute
Robert Wood Johnson Medical School
4:10 - 4:30 Wrap-up Commentary on Thimerosal Risk From the
Perspective of a Pediatric Vaccinologist
Neal Halsey, MD
Professor and Director
Division of Disease Control
Department of International Health
Johns Hopkins University
4:30 - 5:00 Public comment period
5:00 p.m. Adjourn
Back to Meeting